Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NDRAthis companyENDRA Life Sciences Inc.	$4.67	-0.51×	1.58×	0×	-0.48×	-102.5%	0.0%	0.0%	0.0%	-310.9%	-178.3%	-145.8%	0.22×	0.04×	0×	1.29×	0.0%	2	-19.45	2	C+
BBLGBone Biologics Corporation	$0.37	-0.55×	0.32×	0×	1.17×	1037.0%	0.0%	0.0%	0.0%	-57.8%	-60.2%	-158.0%	0×	1.72×	0×	13.85×	0.0%	1	-18.45	2	B-
GCTKGlucoTrack, Inc.	$0.45	-0.18×	1.23×	0×	0.2×	41454.6%	0.0%	0.0%	0.0%	-685.6%	-520.2%	-440.6%	0.01×	0.38×	0×	1.61×	0.0%	1	-186.58	2	B-
HSCSHeartSciences Inc.	$2.95	-0.56×	0.02×	1,185.36×	-275.91×	-25040.1%	-2982.1%	-194787.4%	-211666.5%	-4.1%	-0.2%	-145.9%	17.46×	-275.29×	-11.17×	0.53×	0.0%	1	-41.58	2	C
ISPCiSpecimen Inc.	$0.78	-0.11×	0.39×	0.62×	0.62×	-7973.6%	1.2%	-465.4%	-543.7%	-339.6%	-267.4%	-354.4%	0.09×	0.76×	-4,606.42×	1.12×	0.0%	2	-21.26	2	C
MOVECorvex, Inc.	$5.03	-30.78×	-201.1×	1,613.48×	-46.19×	-100.3%	-424.9%	-3580.4%	-4222.9%	526.3%	-1085.6%	-1.6%	-1.41×	-0.14×	-5.23×	0.57×	0.0%	4	3.97	2	C+
Peer median	—	-0.55×	0.32×	0.62×	0.2×	-100.3%	0.0%	-465.4%	-543.7%	-57.8%	-267.4%	-158.0%	0.01×	0.38×	-5.23×	1.12×	0.0%	1	-21.26	2	—